Veeva Systems (VEEV)
(Delayed Data from NYSE)
$281.35 USD
-2.85 (-1.00%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $281.29 -0.06 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
VEEV 281.35 -2.85(-1.00%)
Will VEEV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VEEV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VEEV
Veeva Systems (VEEV) Stock Moves -1.09%: What You Should Know
Can Veeva's Vault R&D Keep Its Lead Amid Rising AI Competition?
VEEV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Veeva Systems (VEEV) is a Strong Growth Stock
Wall Street Analysts See Veeva (VEEV) as a Buy: Should You Invest?
Does OptimizeRx Have a Moat in the Crowded HealthTech Space?
Other News for VEEV
Franklin Small-Mid Cap Growth Fund Q2 2025 Commentary
Survey Finds Medtechs Lack Confidence in Regulatory Data Quality | VEEV Stock News
Veeva Systems Larger Than S&P 500 Component Target
Veeva Systems Reaches Analyst Target Price
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics